Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
UCT RESEARCH AND DEVELOPMENT INC. maintains a company patent portfolio focused on the Biotechnology & Pharmaceuticals technology area. The portfolio currently includes 1 pending office action, which is assigned to 1 distinct examiner. This arrangement reflects a concentrated prosecution strategy where all pending matters are subject to the review of a single individual. The work is localized within 1 distinct art unit, indicating that the current biotechnology filings fall under a specific technical classification at the USPTO.
The busiest examiner for this entity is XIAO, YAN, who handles 1 busiest examiner pending action. This 1 busiest examiner pending action constitutes the entirety of the company's pending workload. Because the number of distinct examiners is 1, there is no variation in examiner assignment across the current pending applications. This creates a direct and singular line of communication between the company and XIAO, YAN for its Biotechnology & Pharmaceuticals matters.
For a practitioner, the fact that 1 busiest examiner pending action is handled by XIAO, YAN means that the prosecution strategy is entirely dependent on this examiner's specific interpretation. The 1 distinct art unit involved suggests that the company is not currently facing the challenges of navigating multiple different departmental standards. This 1:1:1 ratio of actions to examiners to art units provides a streamlined but centralized prosecution environment for the company's current intellectual property goals.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| XIAO, YAN | 1 | 67.3% | +52.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| Art Unit | Apps |
|---|---|
| 1642 | 1 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial